Appointment of Chief Financial Officer

Spire Healthcare Group plc

("Spire Healthcare", "Spire", "the Company" or "the Group")

Appointment of Chief Financial Officer

London, UK, 17 July 2018: Spire Healthcare Group plc (LSE: SPI), one of the UK's leading independent hospital groups, is pleased to announce the appointment of Jitesh Sodha as Chief Financial Officer and as an Executive Director with effect from 1 October 2018.

Jitesh was formerly CFO of De La Rue, prior to which he was CFO of Greenergy International Limited for seven years. Earlier in his career he held senior positions at Dell Corporation, Cargill and T-Mobile.

Justin Ash, Chief Executive Officer, said: "We are delighted to welcome Jitesh to Spire Healthcare. He brings a wealth of experience and specific skills that will greatly benefit Spire including his track record in helping companies execute ambitious transformation plans. I am confident that he will be a major asset in delivering our strategy of growing revenues from private patients, whilst continuing to support the NHS."

David Lomas will continue as Interim CFO of Spire Healthcare until Jitesh formally joins the Company in October.

There are no matters in respect of Jitesh Sodha requiring disclosure under Listing Rules 9.6.13(2) to 9.6.13(6) inclusive.

-Ends-

For further information please contact:

About Spire Healthcare

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals, 11 clinics and one Specialist Cancer Care Centre across England, Wales and Scotland.

Spire Healthcare delivered tailored, personalised care to approximately 269,300 in-patients and daycase patients in 2017, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. Spire is uniquely positioned to capture a growing share of the rapidly expanding private healthcare market. The Group's well located and scalable hospitals have earned reputations as centres of excellence, delivering successful and award winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. Spire treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.